Delivery Order SPE2DX22D0049-SPE2D826FA4DZ
- Not listed
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $738,887.33 by the Department of Defense's Medical Supply Chain on January 14, 2026, with an ultimate completion date of January 15, 2026. This firm fixed-price, non-set-aside delivery order is a child contract issued under Cencora's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2031....
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $31,343.79 on January 19, 2026, by the Defense Logistics Agency's Medical Supply Chain. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. The ultimate completion date is set for January 20, 2026, and performance will take place at the contractor's corporate office in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $11,187.24 on February 2, 2026, under a competitive, non-set-aside procurement by the Defense Logistics Agency's Medical Supply Chain. The contract is firm fixed price and will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of February 3, 2026. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $61,909.60 by the Defense Logistics Agency Medical Supply Chain on January 12, 2026. This firm fixed-price, non-set-aside contract is scheduled for ultimate completion by January 13, 2026 and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The award represents a task order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $26,876.64 on February 2, 2026, by the Defense Logistics Agency Medical Supply Chain. This firm fixed-price contract, which has no set-aside designation, represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The parent company, Cencora, Inc., holds the primary IDC valued at up to $999,999,999.00 through December 31, 2031, which...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $12,157.17 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price contract was competitively awarded without set-aside designation and calls for performance in Conshohocken, Pennsylvania. The delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $27,771.66 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor and represents a continuation of the company's role as a critical federal medical supply vendor. The contract will be...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $155,719.20 by the Department of Defense's Medical Supply Chain on February 2, 2026, with an ultimate completion date of February 3, 2026. This firm fixed-price, non-set-aside contract represents a child award under Cencora's significant Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support Medical, which is valued at up to $999,999,999.00 through December 2026. The...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., has been awarded a delivery order valued at $10,447.93 by the Defense Logistics Agency's Medical Supply Chain on January 19, 2026. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is scheduled for ultimate completion by January 20, 2026, with performance taking place...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $154,505.14 on January 30, 2026, by the Defense Logistics Agency's Medical Supply Chain. The contract represents a firm fixed-price, non-competitive delivery order with an ultimate completion date of February 2, 2026, and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) with...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D826FA4DZDelivery Order
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., has been awarded a delivery order valued at $31,343.79 by the Defense Logistics Agency's Medical Supply Chain on February 2, 2026, with an ultimate completion date of February 3, 2026. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award to the prime contractor and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at up to $999,999,999.00 through December 2026, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare systems globally. This delivery order exemplifies the company's critical role in federal pharmaceutical procurement, leveraging its existing IDC to fulfill specific medical supply requirements for the Defense Logistics Agency. AmerisourceBergen's contract portfolio demonstrates consistent capability in delivering a comprehensive range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support military treatment facilities, veteran healthcare programs, and other federal medical institutions. The parent company, Cencora, Inc., also maintains a significant single-award IDC with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, underscoring the pharmaceutical distributor's importance to federal healthcare supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.3k | 2/1/26 |